Luis Colomo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.

Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.

Journal: Virchows Archiv : an international journal of pathology

Published: April 30, 2025

Poly (ADP-Ribose) Polymerase 1 and 2 in B-Cell Lymphoma: Pathogenic Roles and Therapeutic Implications.

Poly (ADP-Ribose) Polymerase 1 and 2 in B-Cell Lymphoma: Pathogenic Roles and Therapeutic Implications.

Journal: The American journal of pathology

Published: April 30, 2025

Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas.

Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas.

Journal: Virchows Archiv : an international journal of pathology

Published: August 16, 2024

Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.

Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.

Journal: Cancers

Published: May 11, 2024

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Journal: Cancers

Published: December 09, 2023

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: November 23, 2023

Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.

Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.

Journal: Virchows Archiv : an international journal of pathology

Published: April 06, 2023

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

Journal: Blood advances

Published: June 22, 2022

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.

Journal: Diagnostics (Basel, Switzerland)

Published: May 15, 2022

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Journal: Blood advances

Published: February 17, 2022

Cutaneous Involvement of Angioimmunoblastic T-Cell Lymphoma Masquerading as B-Cell Reactive Lymphoid Hyperplasia.

Cutaneous Involvement of Angioimmunoblastic T-Cell Lymphoma Masquerading as B-Cell Reactive Lymphoid Hyperplasia.

Journal: The American Journal of dermatopathology

Published: December 30, 2021

Sézary syndrome patient-derived models allow drug selection for personalized therapy.

Sézary syndrome patient-derived models allow drug selection for personalized therapy.

Journal: Blood advances

Published: December 17, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026